Crsp Stock Forecast Zacks

Each stock is a zacks rank #1 strong buy. This compares to loss of $1.

Crsp Crispr Therapeutics Ag - Full Company Report - Zackscom

Since then, shares have increased 14.47% to $125.02.

Crsp stock forecast zacks. Four analysts revised their earnings estimate upwards in the last 60 days for fiscal 2021. The zacks consensus estimate has increased $3.67 to $4.81. In the medium term (3months), crsp's stock price.

Crispr therapeutics ag stock forecast by wall street analysts. For fiscal 2021, six analysts revised their earnings. Crsp stock forecast our latest prediction for crispr therapeutics ag's stock price was made on the dec.

The stock is currently a #3 (hold) on the zacks rank. Crispr therapeutics ag () stock market info recommendations: And has now fallen 4 days in a row.

The average crispr therapeutics ag stock forecast from last 6 month is $139.67, and this show a 4.71% increase in average from the prior price target of the each prediction. Crispr therapeutics ag (crsp) came out with a quarterly loss of $1.67 per share versus the zacks consensus estimate of a loss of $1.69. Additionally, crsp's earnings are expected to grow 190.9% for the current fiscal year.

During the day the stock fluctuated 2.51% from a day low at $81.92 to a day high of $83.98. Wall street stock market & finance report, prediction for the future: Crsp, a #3 (hold) stock, was added to the focus list on may 18, 2021 at $109.22 per share.

Crsp boasts an average earnings surprise of 21.6%. You'll find the crispr therapeutics ag share forecasts, stock quote and buy / sell signals below.according to present data crispr therapeutics ag's crsp shares and potentially its. 4, 2017 when the stock price was at 18.26$.

Jun 8, 2021 5:50pm edt. Buy or sell crispr therapeutics ag stock?

Crispr Therapeutics Crsp Q3 Earnings Beat Revenues Lag - November 4 2021 - Zackscom